On the public citation graph
Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome
0 signed · 89 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2012.250openalex-snapshot
Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
inferredcites →https://doi.org/10.1002/hep.20658openalex-snapshot
Natural history of hepatopulmonary syndrome
inferredcites →https://doi.org/10.1002/hep.26070openalex-snapshot
Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era
inferredcites →https://doi.org/10.1002/hep.26632openalex-snapshot
Recurrence of hepatopulmonary syndrome post-orthotopic liver transplantation in a patient with noncirrhotic portal hypertension
inferredcites →https://doi.org/10.1002/hep.30424openalex-snapshot
Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation
inferredcites →https://doi.org/10.1002/hep.30578openalex-snapshot
The Spectrum of Hepatic Involvement in Patients With Telomere Disease
inferredcites →https://doi.org/10.1002/hep.31164openalex-snapshot
Vasomodulators and Liver Transplantation for Portopulmonary Hypertension: Evidence From a Systematic Review and Meta‐Analysis
inferredcites →https://doi.org/10.1002/lt.21545openalex-snapshot
Risk Factors and Impact of Chronic Obstructive Pulmonary Disease in Candidates for Liver Transplantation
inferredcites →https://doi.org/10.1002/lt.21990openalex-snapshot
Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: A single-center study
inferredcites →https://doi.org/10.1002/lt.22066openalex-snapshot
Solitary pulmonary nodule in the liver transplant candidate: Importance of diagnosis and treatment
inferredcites →https://doi.org/10.1002/lt.22339openalex-snapshot
Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: An analysis of the United Network for organ sharing/organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases
inferredcites →https://doi.org/10.1002/lt.23744openalex-snapshot
Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis
inferredcites →https://doi.org/10.1002/lt.24426openalex-snapshot
The utility of pulmonary function testing in predicting outcomes following liver transplantation
inferredcites →https://doi.org/10.1002/lt.25747openalex-snapshot
Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis
inferredcites →https://doi.org/10.1002/lt.25794openalex-snapshot
Prevalence and Impact of Restrictive Lung Disease in Liver Transplant Candidates
inferredcites →https://doi.org/10.1007/978-1-4939-7163-3_26openalex-snapshot
Therapeutic Options in Alpha-1 Antitrypsin Deficiency: Liver Transplantation
inferredcites →https://doi.org/10.1007/s12072-020-10078-2openalex-snapshot
Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.jceh.2016.02.005openalex-snapshot
Long-Term Outcomes of Liver Transplantation for Hepatic Sarcoidosis: A Single Center Experience
inferredcites →https://doi.org/10.1016/j.jhep.2006.12.008openalex-snapshot
Liver involvement in hereditary hemorrhagic telangiectasia (HHT)
inferredcites →https://doi.org/10.1016/j.jhep.2020.06.001openalex-snapshot
High rates of 30-day mortality in patients with cirrhosis and COVID-19
inferredcites →https://doi.org/10.1016/j.prrv.2018.05.010openalex-snapshot
Assessment of liver disease in cystic fibrosis
inferredcites →https://doi.org/10.1016/j.transproceed.2008.02.075openalex-snapshot
Alpha-1-Antitrypsin Deficiency: Outcomes After Liver Transplantation
inferredcites →https://doi.org/10.1016/j.transproceed.2012.02.033openalex-snapshot
Survival of Cystic Fibrosis Patients Undergoing Liver and Liver-Lung Transplantations
inferredcites →https://doi.org/10.1016/s2213-2600(19)30091-8openalex-snapshot
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial
inferredcites →https://doi.org/10.1016/s2468-1253(20)30057-1openalex-snapshot
Liver injury in COVID-19: management and challenges
inferredcites →https://doi.org/10.1016/s2468-1253(20)30116-3openalex-snapshot
COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy
inferredcites →https://doi.org/10.1016/s2468-1253(20)30183-7openalex-snapshot
COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry
inferredcites →https://doi.org/10.1016/s2468-1253(20)30271-5openalex-snapshot
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
inferredcites →https://doi.org/10.1034/j.1600-6143.2003.00197.xopenalex-snapshot
Severe Acute Respiratory Syndrome (SARS) in a Liver Transplant Recipient and Guidelines for Donor SARS Screening
inferredcites →https://doi.org/10.1038/s41575-020-0347-zopenalex-snapshot
COVID-19 and liver transplantation
inferredcites →https://doi.org/10.1053/j.gastro.2008.06.038openalex-snapshot
Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates
inferredcites →https://doi.org/10.1053/j.gastro.2014.01.005openalex-snapshot
Impact of the Hepatopulmonary Syndrome MELD Exception Policy on Outcomes of Patients After Liver Transplantation: An Analysis of the UNOS Database
inferredcites →https://doi.org/10.1053/jhep.2003.50023openalex-snapshot
Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation
inferredcites →https://doi.org/10.1053/jlts.2000.6356openalex-snapshot
Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation
inferredcites →https://doi.org/10.1097/00007890-199605270-00014openalex-snapshot
TRANSPLANTATION FOR END STAGE LIVER DISEASE RELATED TO ALPHA 1 ANTITRYPSIN
inferredcites →https://doi.org/10.1097/01.sla.0000247258.35406.a4openalex-snapshot
Liver Transplantation for Hereditary Hemorrhagic Telangiectasia
inferredcites →https://doi.org/10.1097/mcg.0000000000001289openalex-snapshot
Poor Graft and Patient Survival After Liver Transplantation in Sarcoidosis
inferredcites →https://doi.org/10.1097/meg.0b013e3283311140openalex-snapshot
The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation
inferredcites →https://doi.org/10.1097/tp.0000000000002491openalex-snapshot
Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States
inferredcites →https://doi.org/10.1097/tp.0000000000002716openalex-snapshot
The Utility of ECMO After Liver Transplantation: Experience at a High-volume Transplant Center and Review of the Literature
inferredcites →https://doi.org/10.1097/tp.0000000000002844openalex-snapshot
The Utility of ECMO, Not Just After but Also During Liver Transplantation
inferredcites →https://doi.org/10.1111/ajt.13177openalex-snapshot
Proposed Management Algorithm for Severe Hypoxemia After Liver Transplantation in the Hepatopulmonary Syndrome
inferredcites →https://doi.org/10.1111/j.1399-3046.2010.01460.xopenalex-snapshot
Liver and combined lung and liver transplantation for cystic fibrosis: Analysis of the UNOS database
inferredcites →https://doi.org/10.1111/j.1432-2277.2005.00116.xopenalex-snapshot
Liver transplantation in patients with hepatic hydrothorax
inferredcites →https://doi.org/10.1111/j.1432-2277.2006.00344.xopenalex-snapshot
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry
inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02384.xopenalex-snapshot
Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups
inferredcites →https://doi.org/10.1111/j.1600-6143.2009.02822.xopenalex-snapshot
Improved Survival After Liver Transplantation in Patients with Hepatopulmonary Syndrome
inferredcites →https://doi.org/10.1136/adc.68.5.653openalex-snapshot
Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.
inferredcites →https://doi.org/10.1136/gutjnl-2020-321923openalex-snapshot
COVID-19 in an international European liver transplant recipient cohort
inferredcites →https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2926openalex-snapshot
Short and Long Termoxygenation Outcomes After Liver Transplantation for Hepatopulmonary Syndrome
inferredcites →https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3778openalex-snapshot
Outcomes After Liver Transplantation in Patients with Hepatopulmonary Syndrome in the Pre- and Post-Meld Eras: A Systematic Review
inferredcites →https://doi.org/10.1164/rccm.200701-044ocopenalex-snapshot
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
inferredcites →https://doi.org/10.1183/13993003.01096-2018openalex-snapshot
Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experience
inferredcites →https://doi.org/10.1378/chest.15-0825openalex-snapshot
Hepatopulmonary Syndrome Is a Frequent Cause of Dyspnea in the Short Telomere Disorders
inferredcites →https://doi.org/10.2147/copd.s213257openalex-snapshot
National Trends In Kidney, Heart And Liver Transplants Among Patients With And Without Chronic Obstructive Pulmonary Disease In Spain (2001–2015)
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4797163openalex-extracted
Mesenchymal Stromal Cell Secretome Restores Immune Profile Towards Tissue Regeneration in a Model of Liver Fibrosis with Acute Lung Injury
inferred← citeshttps://doi.org/10.1002/lt.26567openalex-snapshot
Role of extracorporeal membrane oxygenation as a salvage therapy for liver transplantation recipients in a high‐volume transplant center
inferred← citeshttps://doi.org/10.1007/978-3-032-07072-2_18openalex-snapshot
Combined Organ Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-032-07072-2_3openalex-snapshot
Candidate Evaluation for Liver Transplantation
inferred← citeshttps://doi.org/10.1007/978-981-19-7656-8_1openalex-snapshot
Introduction to Lung Disease
inferred← citeshttps://doi.org/10.1007/s00383-023-05533-8openalex-snapshot
Advances in pediatric liver transplantation from the pediatric surgeon’s perspective
inferred← citeshttps://doi.org/10.1007/s12015-026-11235-0openalex-snapshot
Endodermal Organoids Along Two Axes: Single-Organ Fidelity, Inter-Organ Reconstruction, and the Unbuilt Gut-Lung Frontier
inferred← citeshttps://doi.org/10.1007/s12072-023-10590-1openalex-snapshot
How non-alcoholic fatty liver disease and cirrhosis affect the heart
inferred← citeshttps://doi.org/10.1016/j.cgh.2025.07.032openalex-snapshot
Guidance for Timely Referral to Liver Transplantation
inferred← citeshttps://doi.org/10.1016/j.cld.2024.03.005openalex-snapshot
Pulmonary Complications of Portal Hypertension
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.07.032openalex-snapshot
EASL Clinical Practice Guidelines on liver transplantation
inferred← citeshttps://doi.org/10.1016/j.molimm.2026.07.007openalex-snapshot
FoxO1a-mediated Edil3 transcription is impaired in macrophages and exacerbates lung injury after liver transplantation in the aged microenvironment
inferred← citeshttps://doi.org/10.1016/j.rmed.2022.107034openalex-snapshot
Pulmonary hypertension due to high cardiac output
inferred← citeshttps://doi.org/10.1038/s41587-025-02675-zopenalex-snapshot
Dual SORT LNPs for multi-organ base editing
inferred← citeshttps://doi.org/10.1053/j.gastro.2025.05.026openalex-snapshot
Defining Organ Failures in Patients With Cirrhosis: Consensus Statements
inferred← citeshttps://doi.org/10.1055/s-0042-1759613openalex-snapshot
Beyond Varices: Complications of Cirrhotic Portal Hypertension in Pediatrics
inferred← citeshttps://doi.org/10.1097/cld.0000000000000144openalex-snapshot
Inpatient management of fluid overload (ascites, hepatic hydrothorax, and anasarca)
inferred← citeshttps://doi.org/10.1097/hep.0000000000001644openalex-snapshot
AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation
inferred← citeshttps://doi.org/10.1097/mot.0000000000001312openalex-snapshot
Management of patients with cardiopulmonary comorbidities awaiting liver transplantation
inferred← citeshttps://doi.org/10.1097/tp.0000000000005916openalex-snapshot
Impaired Lung Function in Liver Transplant Recipients Compared With the General Population: A Nationwide Matched Cohort Study
inferred← citeshttps://doi.org/10.1111/1751-2980.13294openalex-snapshot
Chinese consensus on the management of liver cirrhosis
inferred← citeshttps://doi.org/10.12998/wjcc.v10.i17.5531openalex-snapshot
Pulmonary complications of portal hypertension: The overlooked decompensation
inferred← citeshttps://doi.org/10.20473/cimrj.v4i2.45201openalex-snapshot
Lung Abnormalities in Liver Cirrhosis
inferred← citeshttps://doi.org/10.21776/ub.crjim.2023.004.02.06openalex-snapshot
Lung Abnormalities in Liver Cirrhosis
inferred← citeshttps://doi.org/10.29328/journal.jprr.1001045openalex-snapshot
Lung Abnormalities in Liver Cirrhosis
inferred← citeshttps://doi.org/10.3350/cmh.2021.0239openalex-snapshot
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
inferred← citeshttps://doi.org/10.3389/ebm.2025.10782openalex-snapshot
Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury
inferred← citeshttps://doi.org/10.36416/1806-3756/e20240350openalex-snapshot
The role of the pulmonary function laboratory in the management of gastrointestinal and liver diseases
inferred← citeshttps://doi.org/10.4103/cjop.cjop-d-22-00131openalex-snapshot
The Pan-liver Network Theory
inferred← citeshttps://doi.org/10.5578/tt.20239612openalex-snapshot
Interstitial lung disease associated with chronic liver disease
inferred← citeshttps://doi.org/10.6002/ect.2025.0205openalex-snapshot
Tidal Volume Challenge to Predict Fluid Responsiveness in Liver Transplant Recipients Ventilated Using Low Tidal Volume.
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.